Global Swab and Viral Transport Medium Market to Reach US$ 2.2 Bn by 2030

In the thick of the COVID-19 pandemic, there is continual demand for swabs and viral transport mediums across the world to conduct tests and control the spread of the infection. This has created a lucrative revenue opportunity for the global swab and viral transport medium market. A new study by Fact.MR projects that the market will surge past a global valuation of US$ 2.2 Bn by the end of 2030.

For detailed insights on enhancing your product footprint, request for a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=5221

Predominantly used across hospitals and laboratories, swab and viral transport medium aid in collecting, transporting, and storing swabs obtained from patients. The collected samples are then tested by microbiologists for the presence of infectious viruses, thereby playing a vital role in the detection of an infection or disease. Rising incidence of contagious diseases caused by viruses such as influenza, herpes simplex virus, rhinovirus, and varicella-zoster virus, among others, is also enabling the growth of the swab and viral transport medium market.

Key Takeaways from Swab and Viral Transport Medium Market Study

• Growing prevalence of infectious diseases and rising awareness among people are expected to act as crucial growth attributes to the market over the coming years.

For critical insights on this market, request for methodology here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=5221

• Based on type, the transport medium segment is expected to account for a majority of value, owing to increasing demand for transporting biosamples for research purposes.
• By application, the viral infection diagnosis segment is poised to account for a lion’s share, ascribed to the high incidence of infections caused by influenza and herpes simplex virus.
• The hospitals & clinics segment is projected to channel a majority of revenue to the swab and viral transport medium market, backed by high inpatient rate for testing.

“While infections such as influenza and herpes ensure healthy long-term growth prospects of the market, the outbreak of COVID-19 is currently catalyzing market growth. Governments across the world are collaborating with healthcare service providers to ensure effective testing and treatment processes, thus positively influencing growth of the swab and viral transport medium market,” remarks a Fact.MR analyst.

Soaring Prevalence of Infectious Diseases Fueling Demand

The threat of infectious diseases has remained a major healthcare concern across both, developed and emerging economies. Influenza is one of the most common infections across the world, causing nearly 650,000 deaths every year.

For comprehensive insights on this market adoption, ask an analyst here- https://www.factmr.com/connectus/sample?flag=AE&rep_id=5221

On this premise, nations are working on raising awareness and improving medical capabilities to lower the mortality rates. With testing being the most effective way to detect the presence of a virus, swab and viral transport mediums are expected to remain highly sought-after by medical institutions across the world.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2018/02/27/1395692/0/en/5-Key-Takeaways-from-Fact-MR-s-Report-on-NGS-Data-Analysis-Market-for-Forecast-Period-2017-2026.html

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: [email protected]
Visit Our Website: https://www.factmr.com